SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-151941
Filing Date
2024-05-31
Accepted
2024-05-31 17:01:02
Documents
13
Period of Report
2024-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d834982d8k.htm   iXBRL 8-K 20877
  Complete submission text file 0001193125-24-151941.txt   145614

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jazz-20240531.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20240531_lab.xml EX-101.LAB 18689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20240531_pre.xml EX-101.PRE 11692
17 EXTRACTED XBRL INSTANCE DOCUMENT d834982d8k_htm.xml XML 3815
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 241010673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)